Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app

J Bousquet, B Sousa-Pinto, J M Anto, R Amaral, L Brussino, G W Canonica, A A Cruz, B Gemicioglu, T Haahtela, M Kupczyk, V Kvedariene, D E Larenas-Linnemann, R Louis, N Pham-Thi, F Puggioni, F S Regateiro, J Romantowski, J Sastre, N Scichilone, L Taborda-BarataM T Ventura, I Agache, A Bedbrook, K C Bergmann, S Bosnic-Anticevich, M Bonini, L-P Boulet, G Brusselle, R Buhl, L Cecchi, D Charpin, C Chaves-Loureiro, W Czarlewski, F de Blay, P Devillier, G Joos, M Jutel, L Klimek, P Kuna, D Laune, J L Pech, M Makela, M Morais-Almeida, R Nadif, M Niedoszytko, K Ohta, N G Papadopoulos, A Papi, D R Yeverino, N Roche, A Sá-Sousa, B Samolinski, M H Shamji, A Sheikh, C Suppli Ulrik, O S Usmani, A Valiulis, O Vandenplas, A Yorgancioglu, T Zuberbier, J A Fonseca

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

BACKGROUND: The self-reporting of asthma frequently leads to patient misidentification in epidemiological studies. Strategies combining the triangulation of data sources may help to improve the identification of people with asthma. We aimed to combine information from the self-reporting of asthma, medication use and symptoms to identify asthma patterns in the users of an mHealth app.

METHODS: We studied MASK-air® users who reported their daily asthma symptoms (assessed by a 0-100 visual analogue scale - "VAS Asthma") at least three times (either in three different months or in any period). K-means cluster analysis methods were applied to identify asthma patterns based on: (i) whether the user self-reported asthma; (ii) whether the user reported asthma medication use and (iii) VAS asthma. Clusters were compared by the number of medications used, VAS asthma levels and Control of Asthma and Allergic Rhinitis Test (CARAT) levels.

FINDINGS: We assessed a total of 8,075 MASK-air® users. The main clustering approach resulted in the identification of seven groups. These groups were interpreted as probable: (i) severe/uncontrolled asthma despite treatment (11.9-16.1% of MASK-air® users); (ii) treated and partly-controlled asthma (6.3-9.7%); (iii) treated and controlled asthma (4.6-5.5%); (iv) untreated uncontrolled asthma (18.2-20.5%); (v) untreated partly-controlled asthma (10.1-10.7%); (vi) untreated controlled asthma (6.7-8.5%) and (vii) no evidence of asthma (33.0-40.2%). This classification was validated in a study of 192 patients enrolled by physicians.

INTERPRETATION: We identified seven profiles based on the probability of having asthma and on its level of control. mHealth tools are hypothesis-generating and complement classical epidemiological approaches in identifying patients with asthma.

Original languageEnglish
JournalPediatric Pulmonology
Early online date22 Nov 2022
Publication statusE-pub ahead of print - 22 Nov 2022

Keywords / Materials (for Non-textual outputs)

  • Asthma
  • Cluster analysis
  • Control
  • Rhinitis
  • Treatment


Dive into the research topics of 'Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app'. Together they form a unique fingerprint.

Cite this